​
Login / Signup
Vester Gunsaru
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 9
Top Topics
Antiretroviral Therapy
Hiv Aids
Emergency Department
Mycobacterium Tuberculosis
Top Venues
BMC medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
Correction: The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)
Vester Gunsaru
,
Marc Yves Romain Henrion
,
Christopher Finn McQuaid
The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries.
BMC medicine
22 (1) (2024)